Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
October 3, 2018
CymaBay Therapeutics Announces Additional Positive Results from its Ongoing Phase 2 Study of Seladelpar in Patients with PBC will be Presented During the Late-Breaking Session at The Liver Meeting®
NEWARK, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), today announced that two late-breaking presentations describing new long-term data from its ongoing ...
October 3, 2018
Zosano Pharma Engages Contract Manufacturer as Part of the Commercialization Strategy for M207
FREMONT, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company developing and commercializing therapies that deliver ...
September 27, 2018
VALNEVA Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors
Saint-Herblain (France), September 27th, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company focused on developing innovative lifesaving vaccines, today announced ...
September 27, 2018
EDAP TMS SA : EDAP Announces the Installation of a Third Focal One® HIFU Device in Brazil
LYON, France, September 27, 2018 -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today announced the installation of the third Focal One ...
September 27, 2018
BioTime to Present at the Upcoming Ladenburg Thalmann and MicroCap Conferences
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that Russell Skibsted, Chief Financial Officer, will present ...
September 27, 2018
Aptose Biosciences and CrystalGenomics Announce Issuance of European Patent for CG-806
SAN DIEGO, TORONTO and SEOUL, South Korea, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), today ...
September 27, 2018
Galmed Pharmaceuticals to Present at the Cantor Global Healthcare Conference, ROTH Battle of the NASH Thrones Investor Conference and Stifel Healthcare Conference
TEL AVIV, Israel, Sept. 27, 2018 /PRNewswire/ --  Galmed Pharmaceuticals Ltd. (GLMD), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 ...
September 27, 2018
Tyme Technologies, Inc. and the Joseph Ahmed Foundation Announce Planned Trial for SM-88 in Ewing’s Sarcoma
NEW YORK, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME) today announced that JAF will provide funding and patient support for an investigator-initiated ...
September 27, 2018
Checkpoint Therapeutics to Present at Ladenburg Thalmann 2018 Healthcare Conference
NEW YORK, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a Fortress Biotech (FBIO) company, today announced that James F. Oliviero, President ...
September 27, 2018
Vaccinex, Inc. to Participate in Podium and Poster Sessions at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
ROCHESTER, N.Y., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat ...
September 27, 2018
Zealand Pharma has initiated the Phase 3 trial with dasiglucagon for treatment of severe hypoglycemia in children
Copenhagen, September 27, 2018 - Zealand Pharma A/S ("Zealand") (ZEAL), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, today ...
September 27, 2018
InspireMD Announces Presentation of Preliminary Cumulative Three-Year CGuard™ EPS Safety and Efficacy Data at the Transcatheter Cardiovascular Therapeutics 2018 Conference
TEL AVIV, Israel, Sept. 27, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
September 27, 2018
Kuros Reports First Patient Treated in Randomized Controlled Trial of MagnetOs in Spinal Fusion
SCHLIEREN (ZURICH), Switzerland, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) today announced that the first patient has been treated in an investigator-led multicenter ...
September 27, 2018
Inventiva: First-half 2018 financial results and business update
Daix (France), September 27, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) ...
September 27, 2018
HTG Molecular Announces Extension to Precision Diagnostic Partnership (PDP) Program Three for Companion Diagnostic Submission
TUCSON, Ariz., Sept. 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, ...
September 26, 2018
HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
TUCSON, Ariz., Sept. 26, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, ...
September 26, 2018
Genkyotex Exceeds Patient Enrollment Target in its Phase 2 Trial with GKT831 for Primary Biliary Cholangitis
Regulatory News: Genkyotex (GKTX.PA) (GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announces today the completion of ...
September 26, 2018
Celyad Appoints Carri Duncan as Vice-President Corporate Development & Communications
MONT-SAINT-GUIBERT, Belgium, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of ...
September 26, 2018
EDAP TMS SA : Houston Methodist Medical Center Research Study Sheds Positive Light on Use of HIFU for Localized Prostate Cancer
AUSTIN, TX - LYON, France, September 26, 2018 - EDAP TMS (EDAP) today announced the results of a study conducted at Houston Methodist Medical Center ...
September 26, 2018
Foamix Pharmaceuticals to Participate in the Cantor Fitzgerald Global Healthcare Conference
REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical-stage specialty pharmaceutical company focused on developing and commercializing ...
Page 14 of 117